Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share Price

Price 34.50p on 05-05-2025 at 18:15:11
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell AVCT Shares
Last Trade: Sell 100,000.00 at 34.00p
Day's Volume: 0
Last Close: 34.00p
Open: 0.00p
ISIN: GB00BYYW9G87
Day's Range 0.00p - 0.00p
52wk Range: 29.25p - 82.50p
Market Capitalisation: £136m
VWAP: 0.00p
Shares in Issue: 393m

Avacta Group (AVCT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100,000 34.00p Ordinary
16:43:24 - 02-May-25
Unknown* 7,278 34.50p Ordinary
16:29:58 - 02-May-25
Sell* 21,130 33.68p Ordinary
16:29:13 - 02-May-25
Buy* 564 34.77p Ordinary
16:28:35 - 02-May-25
Sell* 2,538 33.68p Ordinary
16:25:43 - 02-May-25
Buy* 287 34.7983p Ordinary
16:24:59 - 02-May-25
Buy* 6 34.80p Ordinary
16:21:57 - 02-May-25
Sell* 529 33.68p Ordinary
16:18:16 - 02-May-25
Sell* 39,088 34.49p Ordinary
15:50:24 - 02-May-25
Unknown* 7,518 34.50p Ordinary
15:49:22 - 02-May-25
See more Avacta Group trades

Avacta Group (AVCT) Share Price History

Time period:
to
Date Open High Low Close Volume
5th May 2025 (Mon) 34.00 34.00 34.00 34.00 0
2nd May 2025 (Fri) 33.00 35.00 33.00 34.50 634,370
1st May 2025 (Thu) 33.75 33.75 33.00 33.00 389,559
30th Apr 2025 (Wed) 34.00 34.50 33.00 33.25 842,873
29th Apr 2025 (Tue) 32.50 35.00 32.50 34.00 2,016,923
28th Apr 2025 (Mon) 32.50 34.00 31.50 32.50 4,160,490
25th Apr 2025 (Fri) 31.00 31.50 30.20 31.50 2,150,925
24th Apr 2025 (Thu) 32.50 32.50 30.50 31.00 1,684,493
23rd Apr 2025 (Wed) 34.00 33.00 33.00 33.00 3,189,642
22nd Apr 2025 (Tue) 35.00 34.50 33.00 34.50 1,560,471
21st Apr 2025 (Mon) 35.00 35.00 35.00 35.00 0
18th Apr 2025 (Fri) 35.00 35.00 35.00 35.00 0
17th Apr 2025 (Thu) 37.00 37.00 35.00 35.00 1,450,019
16th Apr 2025 (Wed) 39.50 39.50 37.00 37.00 1,507,178
15th Apr 2025 (Tue) 41.00 41.00 39.00 39.50 1,033,775
14th Apr 2025 (Mon) 38.00 41.00 38.00 41.00 1,194,595
11th Apr 2025 (Fri) 38.00 38.50 37.00 38.00 827,963
10th Apr 2025 (Thu) 36.50 40.00 36.50 38.00 1,714,077
9th Apr 2025 (Wed) 36.00 36.50 35.50 36.00 1,170,611
8th Apr 2025 (Tue) 35.75 38.05 38.05 38.05 1,286,443
7th Apr 2025 (Mon) 32.50 36.25 29.25 35.50 4,495,632
See more Avacta Group price history

Avacta Group (AVCT) Regulatory News

Date Source Headline
29th Apr 2025 7:00 am RNS Board change
28th Apr 2025 5:52 pm RNS Block Listing Six Monthly Return
28th Apr 2025 7:01 am RNS Avacta presents preclinical data at AACR
28th Apr 2025 7:00 am RNS Avacta presents data from lead candidate at AACR
23rd Apr 2025 7:00 am RNS Issue of Equity and Total Voting Rights
31st Mar 2025 7:00 am RNS Avacta Quarterly Update
26th Mar 2025 7:00 am RNS Avacta Announces Presentations at AACR
25th Mar 2025 7:00 am RNS Avacta Completes Launch Diagnostics Sale
10th Mar 2025 7:00 am RNS Avacta to Present at Leerink Healthcare Conference
7th Mar 2025 8:40 am RNS Avacta announces data update for AVA6000
See more Avacta Group regulatory news

Avacta Group (AVCT) Share News

Avacta sells Launch Diagnostics; reports "promising" efficacy data

7th Mar 2025 12:42

(Alliance News) - Avacta Group PLC on Friday said it has agreed to sell its UK-based and largest diagnostics unit, Launch Diagnostics Holdings Ltd, and reported "promising" early efficacy data in the treatment of salivary gland cancers. Read More

AIM WINNERS & LOSERS: Avacta makes progress on AVA6000 testing

7th Mar 2025 10:28

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

EXECUTIVE CHANGES: Various Eateries hires Young's executive as CEO

13th Jan 2025 14:59

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

10th Dec 2024 10:01

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

Avacta partners with Tempus to enable AI-driven drug development

21st Oct 2024 14:31

(Alliance News) - Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus AI Inc, to optimise its clinical development process and enable "the highest probability of success". Read More

See more Avacta Group news
FTSE 100 Latest
Value8,596.35
Change99.55

Login to your account

Forgot Password?

Not Registered